JENNIFER BABOOLALL: Open Payments
NPI 1598220154 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 15 payments from 7 companies in 2025. Trend: 2023 $428 · 2024 $641 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Novo Nordisk Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: VRAYLAR, JARDIANCE, Ozempic, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, BREZTRI, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
